CFLT Insider Sale: 37,707 Shares Sold Under 10b5-1 Plan

Rhea-AI Filing Summary

Edward Jay Kreps, who serves as Chief Executive Officer and a director of Confluent, Inc. (CFLT), reported an amendment to his Form 4 disclosing a sale of 37,707 shares of Class A common stock executed under a 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $21.63 to $22.00, with a weighted reference price reported on the form as $21.84.

Following the reported disposition, Mr. Kreps beneficially owned 414,781 shares of Class A common stock. The amended filing restates and replaces the earlier Form 4 previously submitted by the reporting person.

Positive

• Transaction executed under a 10b5-1 plan, indicating trades were pre-arranged and compliant with Rule 10b5-1
• Amended Form 4 filed to restate and clarify prior disclosure, improving transparency

Negative

• Insider sold 37,707 Class A shares, which reduces the reporting persons direct holdings
• Sales occurred at prices between $21.63 and $22.00, representing a realized disposal at those price levels

Insights

Corporate Governance Expert

TL;DR: Routine insider sale under a documented 10b5-1 plan; amendment improves disclosure clarity.

The filing shows a planned disposition of 37,707 Class A shares under a 10b5-1 plan adopted August 15, 2024, with sale prices between $21.63 and $22.00. The amendment restates the prior Form 4, indicating the reporting person corrected or clarified earlier reporting. From a governance perspective, use of a 10b5-1 plan and an amended filing are consistent with compliance and predictable disclosure practices, reducing ambiguity about the timing and permissibility of the trades.

Securities Analyst

TL;DR: Insider sold a meaningful lot of shares but retains a sizable stake; transaction appears pre-planned.

The sale of 37,707 shares at prices in the $21.63–$22.00 range reduces the reporting persons immediate holdings while leaving a reported beneficial ownership of 414,781 shares. Because the trades were executed pursuant to a 10b5-1 plan, the transactions likely reflect pre-scheduled liquidity rather than opportunistic trading, which tends to be viewed neutrally by investors absent other information.

Insider Trade Summary

Net Seller: 37,707 shares ($823,521)

Net Sell 1 txn

Insider Kreps Edward Jay

Role CHIEF EXECUTIVE OFFICER

Sold 37,707 shs ($824K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	37,707	$21.84	$824K

Holdings After Transaction: Class A Common Stock — 414,781 shares (Direct)

Footnotes (1)

1. Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $21.63 to $22.00. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kreps Edward Jay

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/22/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/20/2025		S		37,707(1)	D	$21.84(2)	414,781	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024.

2. The shares were sold at prices ranging from $21.63 to $22.00. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

This Form 4/A amends and restates in its entirety the Form 4 filed on May 22, 2025 by the Reporting Person.

	/s/ Weilyn Wood, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Confluent CEO Edward Kreps report on Form 4/A?

The filing reports a sale of 37,707 Class A common shares executed under a 10b5-1 trading plan, with sale prices ranging from $21.63 to $22.00.

How many Confluent (CFLT) shares does Edward Kreps own after the reported sale?

The Form 4/A shows Mr. Kreps beneficially owns 414,781 shares of Class A common stock following the reported disposition.

Were the sales part of a planned trading arrangement for CFLT shares?

Yes. The shares were sold pursuant to a 10b5-1 trading plan adopted August 15, 2024, as stated in the filing.

What price range did the insider sales occur at for CFLT?

The shares were sold at prices ranging from $21.63 to $22.00, and the reporting person offered to provide detailed per-price share counts upon request.

Does the Form 4/A replace a previous filing?

Yes. The document states it amends and restates the Form 4 previously filed by the reporting person.